Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance

J Gonzalez-Molina, L Moyano-Galceran… - Seminars in Cancer …, 2022 - Elsevier
The development of most solid cancers, including pancreatic, breast, lung, liver, and ovarian
cancer, involves a desmoplastic reaction: a process of major remodeling of the extracellular …

[HTML][HTML] Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma

SK Gautam, SK Batra, M Jain - Molecular cancer, 2023 - Springer
Immunosuppression is a hallmark of pancreatic ductal adenocarcinoma (PDAC),
contributing to early metastasis and poor patient survival. Compared to the localized tumors …

[HTML][HTML] Targeted anti-mitochondrial therapy: the future of oncology

F Taghizadeh-Hesary, H Akbari, M Bahadori… - Genes, 2022 - mdpi.com
Like living organisms, cancer cells require energy to survive and interact with their
environment. Mitochondria are the main organelles for energy production and cellular …

[HTML][HTML] Focal adhesion kinase: from biological functions to therapeutic strategies

X Tan, Y Yan, B Song, S Zhu, Q Mei, K Wu - Experimental Hematology & …, 2023 - Springer
Focal adhesion kinase (FAK), a nonreceptor cytoplasmic tyrosine kinase, is a vital
participant in primary cellular functions, such as proliferation, survival, migration, and …

[HTML][HTML] Functional and clinical characteristics of focal adhesion kinases in cancer progression

Z Zhang, J Li, S Jiao, G Han, J Zhu… - Frontiers in Cell and …, 2022 - frontiersin.org
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and an adaptor protein that
primarily regulates adhesion signaling and cell migration. FAK promotes cell survival in …

Regulation of pancreatic cancer therapy resistance by chemokines

SK Gautam, S Basu, A Aithal, NV Dwivedi… - Seminars in cancer …, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy characterized by
high resistance and poor response to chemotherapy. In addition, the poorly immunogenic …

[HTML][HTML] Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer

H Sun, D Zhang, C Huang, Y Guo, Z Yang… - Cancer Biology & …, 2021 - ncbi.nlm.nih.gov
Objective: Hypoxia is a significant feature of solid tumors, including pancreatic ductal
adenocarcinoma (PDAC). It is associated with tumor invasion, metastasis, and drug …

Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy

KJ Murphy, J Zhu, M Trpceski, BA Pereira… - Biochemical Society …, 2022 - portlandpress.com
The dense desmoplastic and fibrotic stroma is a characteristic feature of pancreatic ductal
adenocarcinoma (PDAC), regulating disease progression, metastasis and response to …

[HTML][HTML] Focal adhesion kinase inhibitors, a heavy punch to cancer

Y Wu, N Li, C Ye, X Jiang, H Luo, B Zhang, Y Zhang… - Discover Oncology, 2021 - Springer
Kinases are the ideal druggable targets for diseases and especially were highlighted on
cancer therapy. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and its …

Molecular docking, molecular dynamics simulations, and free energy calculation insights into the binding mechanism between vs-4718 and focal adhesion kinase

M Shi, T Chen, S Wei, C Zhao, X Zhang, X Li… - ACS …, 2022 - ACS Publications
Focal adhesion kinase (FAK) is a 125 kDa nonreceptor tyrosine kinase that plays an
important role in many carcinomas. Thus, the targeting of FAK by small molecules is …